Trastuzumab deruxtecan
Daiichi Sankyo,Astrazeneca
['rux,(-crux),(-trux)']
 it always seemed to me that "her-2 low" was just a way to expand the market for tras deruxtecan. i have no objection to this - it seems to work!
I ask good questions